Emgality
galcanezumab
Migraine Disorders
Date of authorisation:
Revision: 11
Last updated:
MedicineHumanAuthorised
EMEA-001860-PIP03-16-M08 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Neurology
PIP number: P/0030/2023
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Puldysa
idebenone
Date of withdrawal:
Last updated:
MedicineHumanWithdrawn application
EMEA-001860-PIP04-16 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Neurology
PIP number: P/0365/2016
Route(s) of administration: Subcutaneous use
Pharmaceutical form(s):
Solution for injection
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
P/90/2010 - paediatric investigation plan
Decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
Therapeutic area: Dermatology
PIP number: P/90/2010
Route(s) of administration: Cutaneous use
Pharmaceutical form(s):
Cream
Decision date:
Last updated:
Compliance check: ✖
PIPHuman